USPTO Gene Test Fight Pits Patients Against Patents

Law360, New York (February 16, 2012, 5:06 PM ET) -- The two sides in the heated debate over patents for genetic diagnostic tests clashed Thursday at a U.S. Patent and Trademark Office hearing, with doctors and advocates claiming gene patents can hurt patients, and attorneys and biotechnology companies defending strong patent rights.

The America Invents Act gives the USPTO until June to submit a report to Congress on the impact that patents for genetic diagnostic tests have on medical practice. A breast cancer test offered by Myriad Genetics Inc. is at the center of a suit...
To view the full article, register now.